Major Pharma is Paying Top Dollar for Late Stage Products to Bolster Flagging Pipelines
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 25 (Table of Contents)
Published: 2 Jun-2002
DOI: 10.3833/pdr.v2002.i25.1048 ISSN: 1756-7874
Section: General
Abstract
The pharmaceutical sector growth is fuelled by blockbuster drugs...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
Last Issue PDF
RSS